drugset / Trial / NCT01381770
Platelet-derived Factors for Treatment of Muscular Lesions
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate that platelet-derived repairing factors are effective and safe in the treatment of muscular lesion grade 2 or 3, a Phase II, open-label, single arm, single centre has been designed. Sample size will be 25.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-12
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | platelet-derived repairing factors | Unknown | — | Other |
Indications
No indication recorded.